FDA Inspection
Cohance Lifesciences LimitedCohance Lifesciences Limited – FDA Inspection, Mar 1, 2019
Record Details
This FDA Inspection record concerns Cohance Lifesciences Limited, with an inspection on March 1, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d292ee89-2212-427b-8fc0-c520be0929d7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1087850
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cohance Lifesciences Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 11, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 2, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cohance Lifesciences Limited
- FDA Inspection 1289854 - 2025-09-11
- FDA Inspection 978256 - 2016-04-01
- FDA Inspection 794863 - 2012-08-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.